Dachaigh › Lymphoma Cealla-T
Sgrùdaidhean clionaigeach Lymphoma Cealla-T a’ fastadh anns na SA
Tha 36 sgrùdaidhean airson Lymphoma Cealla-T a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- New York City, NY13 sgrùdaidhean
- Philadelphia, PA10 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Boston, MA9 sgrùdaidhean
- Houston, TX8 sgrùdaidhean
- Atlanta, GA8 sgrùdaidhean
- Rochester, MN6 sgrùdaidhean
- Columbus, OH6 sgrùdaidhean
- Chicago, IL6 sgrùdaidhean
- Seattle, WA6 sgrùdaidhean
- New Haven, CT5 sgrùdaidhean
- Miami, FL5 sgrùdaidhean
- Scottsdale, AZ4 sgrùdaidhean
- St. Louis, MO4 sgrùdaidhean
- Durham, NC4 sgrùdaidhean
- Cedar Rapids, IA4 sgrùdaidhean
- Portland, OR4 sgrùdaidhean
- Ann Arbor, MI4 sgrùdaidhean
- Baltimore, MD4 sgrùdaidhean
- Charlottesville, VA4 sgrùdaidhean
- San Diego, CA3 sgrùdaidhean
- Charlotte, NC3 sgrùdaidhean
- Washington, DC3 sgrùdaidhean
- Aurora, CO3 sgrùdaidhean
- East Norwalk, CT3 sgrùdaidhean
- Omaha, NE3 sgrùdaidhean
- Edison, NJ3 sgrùdaidhean
- Staten Island, NY3 sgrùdaidhean
- New Rochelle, NY3 sgrùdaidhean
- Tampa, FL3 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
- Queens, NY3 sgrùdaidhean
- Denver, CO3 sgrùdaidhean
- Madison, WI3 sgrùdaidhean
- Minneapolis, MN3 sgrùdaidhean
- Salt Lake City, UT3 sgrùdaidhean
- Los Angeles, CA3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Milwaukee, WI3 sgrùdaidhean
- Indianapolis, IN3 sgrùdaidhean
Le stàit
- Arizona5 sgrùdaidhean
- California13 sgrùdaidhean
- Colorado6 sgrùdaidhean
- Connecticut5 sgrùdaidhean
- Florida8 sgrùdaidhean
- Georgia8 sgrùdaidhean
- Illinois7 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Iowa4 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts9 sgrùdaidhean
- Michigan5 sgrùdaidhean
- Minnesota9 sgrùdaidhean
- Missouri4 sgrùdaidhean
- Nebraska3 sgrùdaidhean
- New Jersey4 sgrùdaidhean
- New York15 sgrùdaidhean
- North Carolina6 sgrùdaidhean
- Ohio8 sgrùdaidhean
- Oklahoma3 sgrùdaidhean
- Oregon4 sgrùdaidhean
- Pennsylvania12 sgrùdaidhean
- Texas9 sgrùdaidhean
- Utah3 sgrùdaidhean
- Virginia5 sgrùdaidhean
- Washington6 sgrùdaidhean
- Wisconsin5 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07388563Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04234048Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04803201Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06561048BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT04752826Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06724237A Study of Ruxolitinib and Duvelisib in People With Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05010005A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06854653A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT04104776Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07382817Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
A’ fastadhÌre 2
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06390319CD45BE-HSPC + CART-45 Cells
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07451054Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07750886Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07293403Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT03011814Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
A’ fastadhÌre 1
Aoisean 0 gu 29 · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT06934382Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT03501576Allo HSCT Using RIC and PTCy for Hematological Diseases
A’ fastadhÌre 2
Suas gu aois 75 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT05805605Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06508463CD4CAR for CD4+ Leukemia and Lymphoma
A’ fastadhÌre 1
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT03829540A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Ògmh 2026 · NCT05463263Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Ògmh 2026 · NCT05313243A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT03017820Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT07278856Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.